Avalon GloboCare Corp. is a commercial-stage company engaged in developing and delivering precision diagnostic consumer products and the advancement of intellectual property in cellular therapy. The Company operates in two reportable business segments: the real property operating segment and the laboratory testing services segment. Its laboratory services offer a test menu that satisfies the clients' testing needs, from general bloodwork to anatomic pathology, urine toxicology, pharmacogenomics (PGx) testing and more, and it is a one-stop-shop for clinical testing. The Company is currently marketing the KetoAir breathalyzer device and plans to develop additional diagnostic uses of the breathalyzer technology. The KetoAir breathalyzer is a handheld device that allows the user to detect acetone levels in exhaled breath. The acetone level is in concentration units part-per-million (ppm) such that the user knows the real-time ketosis status.
企業コードALBT
会社名Avalon Globocare Corp
上場日Feb 22, 2016
最高経営責任者「CEO」Jin (David)
従業員数5
証券種類Ordinary Share
決算期末Feb 22
本社所在地4400 Route 9
都市FREEHOLD
証券取引所NASDAQ OMX - NASDAQ BASIC
国United States of America
郵便番号07728
電話番号17327804400
ウェブサイトhttps://www.avalon-globocare.com/
企業コードALBT
上場日Feb 22, 2016
最高経営責任者「CEO」Jin (David)
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし